Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
May 12, 2023
Orthofix announced the first patient implant in a U.S. Food and Drug Administration (FDA) clinical study that will evaluate the safety and effectiveness of the M6-C™ artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of contiguous two-level symptomatic cervical radiculopathy. “Artificial cervical disc replacement is rapidly becoming the standard…
